Assessing Surmodics: Insights From 5 Financial Analysts
Assessing Surmodics: Insights From 5 Financial Analysts
評估Surmodics：來自5位金融分析師的見解
Surmodics (NASDAQ:SRDX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，Surmodics（納斯達克：SRDX）已被5名分析師分析，顯示出從看好到看淡的各種不同觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖，顯示了過去30天的不同情緒，並將其與前幾個月進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $49.4, a high estimate of $71.00, and a low estimate of $43.00. Experiencing a 16.27% decline, the current average is now lower than the previous average price target of $59.00.
分析師分析的12個月價格目標提供了洞察力，平均目標爲49.4美元，最高估值爲71.00美元，最低估值爲43.00美元。股價目前已經下跌了16.27％，當前平均目標低於之前的59.00美元的平均價格目標。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級：分析師評級的深度探討
The perception of Surmodics...
金融專家...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。